Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Thyssenkrupp Nucera Reports 2023/24 Fiscal Year Results with Operating Loss Narrower Than Expected

Credit: Thyssenkrupp Nucera

AG & Co KgaA has met its sales guidance for the 2023/24 fiscal year, reporting an operating loss that was slightly smaller than initially anticipated.

According to preliminary results released on Tuesday, the company's EBIT for the period was “slightly better” than expected, falling within the negative mid-double-digit million euro range. This compares with a positive EBIT of EUR 23.8 million (USD 25.1 million) in the 2022/23 fiscal year.

The decline in EBIT was attributed to the build-up of its alkaline water electrolysis (AWE) capacity and higher (R&D) expenses, which impacted profitability.

Despite this, the company's sales for the 12-month period are expected to be within the EUR 820 million-900 million forecast, with AWE sales falling within the EUR 500 million-550 million range. The AWE business benefitted from projects in and , while chlor-alkali (CA) electrolysers showed a slight increase in sales.

Order intake exceeded the prior year's level, driven by AWE orders, although CA order intake was lower, due in part to a large order from OxyChem in the previous year.

In Q4 alone, Thyssenkrupp Nucera recorded all-time-high AWE sales, with CA sales largely unchanged from the same quarter in the prior year. However, increased capacity expansion costs and a lower gross margin led to a decline in quarterly EBIT, although it still exceeded the company's initial expectations.

Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use